Abuse liability assessment of atomoxetine in a drug-abusing population-Reference-Cited by-同舟云学术

Abuse liability assessment of atomoxetine in a drug-abusing population

Published:2008-05 Issue:1-2 Volume:95 Page:140-146
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Jasinski Donald R.,Faries Douglas E.,Moore Rodney J.,Schuh Leslie M.,Allen Albert J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference34 articles.

1. Guidelines and methodological reviews concerning drug abuse liability assessment;Balster;Drug Alcohol Depend.,2003

2. Evaluation of phentermine and fenfluramine alone and in combination, in normal, healthy volunteers;Brauer;Neuropsychopharmacology,1996

3. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder;Bymaster;Neuropsychopharmacology,2002

4. The National Center on Addiction and Substance Abuse (CASA) at Columbia University, 2005. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S. CASA, New York.

5. Experimental Designs;Cochran,1957

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IUPHAR review – Data-driven computational drug repurposing approaches for opioid use disorder;Pharmacological Research;2024-01

2. Functional Impairments Associated With ADHD in Adulthood and the Impact of Pharmacological Treatment;Journal of Attention Disorders;2023-03-06

3. Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design;Drug Development and Industrial Pharmacy;2022-11-02

4. The Effects of Drug Treatments for ADHD in Measures of Cognitive Performance;New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder;2022

5. Treatment;Adult ADHD;2021-10-22